Expertos Invitados





MELATONINA COMO NEUROPROTECTOR Y PROMOTOR DEL SUEÑO

(especial para SIIC © Derechos reservados)
Se sabe desde hace un cuarto de siglo que la administración de melatonina induce sueño en el hombre. Esta hormona reduce la latencia para el sueño y aumenta su eficiencia, en particular en lo referido al sueño lento.
Autor:
Daniel p. Cardinali
Columnista Experto de SIIC
Artículos publicados por Daniel p. Cardinali
Coautor
Luis I. Brusco* 
Dr., Buenos Aires, Argentina*
Recepción del artículo
8 de Noviembre, 2000 		Aprobación
19 de Abril, 2001
Primera edición
23 de Abril, 2001 		Segunda edición, ampliada y corregida
7 de Junio, 2021

MELATONINA COMO NEUROPROTECTOR Y PROMOTOR DEL SUEÑO


Artículo completo
(castellano)
Extensión:  +/-5.19 páginas impresas en papel A4
Exclusivo para suscriptores/assinantes
Clasificación en siicsalud
Artículos originales > Expertos de Iberoamérica >
página   www.siicsalud.com/des/expertocompleto.php/

Especialidades
Principal: Neurología
Relacionadas: Diagnóstico por Laboratorio, Endocrinología y Metabolismo, Farmacología, Geriatría, Medicina Interna, Salud Mental, Salud Pública



Comprar este artículo
Extensión: 5.19 páginas impresas en papel A4

file05.gif (1491 bytes) Artículos seleccionados para su compra



Bibliografía del artículo

1. Cardinali DP, Pevet P. «Basic aspects of melatonin action», Sleep Med Rev 1998; 2:175-190.
2. Lavie P. «Sleep-wake as a biological rhythm», Annu Rev Psychol 2001; 52:277-303.
3. Monti JM, Cardinali DP. «A critical assessment of the melatonin effect on sleep in humans», Biol Signals Recept 2000; 9:328-339.
4. Myers BL, Badia P. «Changes in circadian rhythms and sleep quality with aging: mechanisms and interventions», Neurosci Biobehav Rev 1995; 19:553-571.
5. de la Calzada MD. «Modificaciones del sueño en el envejecimiento», Rev Neurol 2000; 30:577-580.
6. Vitiello MV. «Effective treatment of sleep disturbances in older adults», Clin Cornerstone 2000; 2:16-27.
7. Garfinkel D, Laudon M, Nof D, Zisapel N. «Improvement of sleep quality in elderly people by controlled-release melatonin», Lancet 1995; 346:541-544.
8. Ferrari E, Magri F, Locatelli M, Balza G, Nescis T, Battegazzore C, Cuzzoni G, Fioravanti M, Solerte SB. «Chrono-neuroendocrine markers of the aging brain», Aging (Milano) 1996; 8:320-327.
9. Touitou Y. «Effects of ageing on endocrine and neuroendocrine rhythms in humans», Horm Res 1995; 43:12-19.
10. Vollrath L, Semm P, Gammel G. «Sleep induction by intranasal administration of melatonin», Adv Biosci 1981; 29:327-329.
11. Lavie P. «Melatonin: role in gating nocturnal rise in sleep propensity», J Biol Rhythms 1997; 12:657-665.
12. Lewy AJ, Ahmed S, Jackson JM, Sack RL. «Melatonin shifts human circadian rhythms according to a phase-response curve», Chronobiol Int 1992; 9:380-392.
13. Arendt J. «Melatonin, circadian rhythms, and sleep», N Engl J Med 2000; 343:1114-1116.
14. Dollins AB, Zhdanova IV, Wurtman RJ, Lynch HJ, Deng MH. «Effect of inducing nocturnal serum melatonin concentrations in daytime on sleep, mood, body temperature, and performance», Proc Natl Acad Sci USA 1994; 91:1824-1828.
15. Stone BM, Turner C, Mills SL, Nicholson AN. «Hypnotic activity of melatonin», Sleep 2000; 23:663-669.
16. Sack RL, Brandes RW, Kendall AR, Lewy AJ. «Entrainment of free-running circadian rhythms by melatonin in blind people», N Engl J Med 2000; 343:1070-1077.
17. Shochat T, Luboshitzky R, Lavie P. «Nocturnal melatonin onset is phase locked to the primary sleep gate», Am J Physiol 1997; 273:R364-R370.
18. Kabuto M, Namura I, Saitoh Y. «Nocturnal enhancement of plasma melatonin could be suppressed by benzodiazepines in humans», Endocrinol Jpn 1986; 33:405-414.
19. Brugger P, Marktl W, Herold M. «Impaired nocturnal secretion of melatonin in coronary heart disease [see comments]», Lancet 1995; 345:1408.
20. Fiorina P, Lattuada G, Ponari O, Silvestrini C, DallAglio P. «Impaired nocturnal melatonin excretion and changes of immunological status in ischaemic stroke patients», Lancet 1996; 347:692-693.
21. Girotti L, Lago M, Yanovsky O, Carbajales J, Elizari M, Brusco LI, Cardinali DP. «Low urinary 6-sulphatoxymelatonin levels in patients with coronary artery disease», J Pineal Research 2000; 29:138-142.
22. MacFarlane JG, Cleghorn JM, Brown GM, Streiner DL. «The effects of exogenous melatonin on the total sleep time and daytime alertness of chronic insomniacs: a preliminary study», Biol Psychiatry 1991; 30:371-376.
23. Haimov I, Laudon M, Zisapel N, Souroujon M, Nof D, Shlitner A, Herer P, Tzischinsky O, Lavie P. «Sleep disorders and melatonin rhythms in elderly people», BMJ 1994; 309:167
24. Hajak G, Rodenbeck A, Bandelow B, Friedrichs S, Huether G, Ruther E. «Nocturnal plasma melatonin levels after flunitrazepam administration in healthy subjects», Eur Neuropsychopharmacol 1996; 6:149-153.
25. Hughes RJ, Sack RL, Lewy AJ. «The role of melatonin and circadian phase in age-related sleep- maintenance insomnia: assessment in a clinical trial of melatonin replacement», Sleep 1998; 21:52-68.
26. James SP, Sack DA, Rosenthal NE, Mendelson WB. «Melatonin administration in insomnia5, Neuropsychopharmacology 1990; 3:19-23.
27. Ellis CM, Lemmens G, Parkes JD. «Melatonin and insomnia», J Sleep Res 1996; 5:61-65.
28. Haimov I, Lavie P, Laudon M, Herer P, Vigder C, Zisapel N. «Melatonin replacement therapy of elderly insomniacs5, Sleep 1995; 18:598-603.
29. Fainstein I, Bonetto A, Brusco LI, Cardinali DP. «Effects of melatonin in elderly patients with sleep disturbance. A pilot study», Curr Ther Res 1997; 58:990-1000.
30. Dagan Y, Zisapel N, Nof D, Laudon M, Atsmon J. «Rapid reversal of tolerance to benzodiazepine hypnotics by treatment with oral melatonin: a case report», Eur Neuropsychopharmacol 1997; 7:157-160.
31. Wurtman RJ, Zhdanova I. «Improvement of sleep quality by melatonin», Lancet 1995; 346:1491
32. Siegrist C, Benedetti C, Orlando A, Beltrán JM, Tuchscherr.L., Noseda CMJ, Brusco LI, Cardinali DP. «Lack of changes in serum prolactin, FSH, TSH and estradiol after melatonin treatment in doses that improve sleep and reduce benzodiazepine consumption in sleep-disturbed, middle aged and elderly patients», J Pineal Res 2001; 30:34-42.
33. Brusco LI, Fainstein I, Marquez M, Cardinali DP. «Effect of melatonin in selected populations of sleep-disturbed patients», Biol Signals Recept 1999; 8:126-131.
34. Gonzal=ez R, Sanchez A, Ferguson JA, Balmer C, Daniel C, Cohn A, Robinson WA. «Melatonin therapy of advanced human malignt melanoma5, Melanoma Res 1991; 1:237-243.
35. Seabra MLV, Bignotto M, Pinto LR, Tufik S. «Randomized, double-blind clinical trial, controlled with placebo, of the toxicology of chronic melatonin treatment», J Pineal Res 2000; 29:193-200.
36. Monti JM, Alvarino F, Cardinali D, Savio I, Pintos A. «Polysomnographic study of the effect of melatonin on sleep in elderly patients with chronic primary insomnia», Arch Gerontol Geriatr 1999; 28:85-98.
37. Copinschi G, Van Cauter E. «Effects of ageing on modulation of hormonal secretions by sleep and circadian rhythmicity», Horm Res 1995; 43:20-24.
38. Citera G, Arias MA, Maldonado-Cocco JA, Lazaro MA, Rosemffet MG, Brusco LI, Scheines EJ, Cardinali DP. «The effect of melatonin in patients with fibromyalgia: A pilot study», Clin Rheumatol 2000; 19:9-13.
39. Pappolla M, Bozner P, Soto C, Shao H, Robakis NK, Zagorski M, Frangione B, Ghiso J. «Inhibition of Alzheimer beta-fibrillogenesis by melatonin», J Biol Chem 1998; 273:7185-7188.
40. Chyan YJ, Poeggeler B, Omar RA, Chain DG, Frangione B, Ghiso J, Pappolla MA. «Potent neuroprotective properties against the Alzheimer beta-amyloid by an endogenous melatonin-related indole structure, indole-3-propionic acid», J Biol Chem 1999; 274:21937-21942.
41. Liu RY, Zhou JN, van Heerikhuize J, Hofman MA, Swaab DF. «Decreased melatonin levels in postmortem cerebrospinal fluid in relation to aging, Alzheimer\'s disease, and apolipoprotein E-epsilon4/4 genotype», J Clin Endocrinol Metab 1999; 84:323-327.
42. Reiter RJ, Garcia JJ, Pie J. «Oxidative toxicity in models of neurodegeneration: Responses to melatonin», Restorative Neurol Neurosci 1998; 12:135-142.
43. Brusco LI, Marquez M, Cardinali DP. «Monozygotic twins with Alzheimer\'s disease treated with melatonin: Case report», J Pineal Res 1998; 25:260-263.
44. Brusco LI, Marquez M, Cardinali DP. «Melatonin treatment stabilizes chronobiologic and cognitive symptoms in Alzheimer\'s disease», Neuroendocrinol Lett 1998; 19:111-115.
45. Cohen-Mansfield J, Garfinkel D, Lipson S. «Melatonin for treatment of sundowning in elderly persons with demen», Arch Gerontol Geriatr 2000; 31:65-76.
46. Mishima K, Okawa M, Hozumi S, Hishikawa Y. «Supplementary administration of artificial bright light and melatonin as potent treatment for disorganized circadian rest-activity and dysfunctional autonomic and neuroendocrine systems in institutionalized demented elderly persons», Chronobiol Int 2000; 17:419-432.
47. Reiter RJ, Tan D, Qi W, Manchester LC, Karbownik M, Calvo JR. «Pharmacology and physiology of melatonin in the reduction of oxidative stress in vivo», Biol Signals Recept 2000; 9:160-171.
48. Uz T, Giusti P, Franceschini D, Kharlamov A, Manev H. «Protective effect of melatonin against hippocampal DNA damage induced by intraperitoneal administration of kainate to rats», Neuroscience 1996; 73:631-636.
49. Reiter RJ, Guerrero JM, Garcia JJ, Acuna-Castroviejo D. «Reactive oxygen intermediates, molecular damage, and aging. Relation to melatonin», Ann N Y Acad Sci 1998; 854:410-424.
50. Benot S, Goberna R, Reiter RJ, Garcia-Maurino S, Osuna C, Guerrero JM. «Physiological levels of melatonin contribute to the antioxidant capacity of human serum», J Pineal Res 1999; 27:59-64.
Título español
 Bibliografía
 Artículo completo
(exclusivo a suscriptores)
 Autoevaluación
  Tema principal en SIIC Data Bases
 Especialidades

  English title
  Abstract
  Key words
Full text
(exclusivo a suscriptores)

Autor 
Artículos
Correspondencia

Patrocinio y reconocimiento
Imprimir esta página
 
 
 
 
 
 
 
 
 
 
 
 
Está expresamente prohibida la redistribución y la redifusión de todo o parte de los contenidos de la Sociedad Iberoamericana de Información Científica (SIIC) S.A. sin previo y expreso consentimiento de SIIC.
ua31618
Inicio/Home

Copyright siicsalud © 1997-2025 ISSN siicsalud: 1667-9008